BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21637070)

  • 1. FDG PET imaging in a patient with primary seminoma of the prostate.
    Hayasaka K; Koyama M; Fukui I
    Clin Nucl Med; 2011 Jul; 36(7):593-4. PubMed ID: 21637070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
    Dong A; Zuo C; Lu J; Wang Y
    Clin Nucl Med; 2014 Jul; 39(7):650-2. PubMed ID: 23877521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
    Yilmaz M; Celen Z; Sevinc A; Karakok M
    Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate.
    Dong A; Gong J; Wang Y; Zuo C
    Clin Nucl Med; 2014 Oct; 39(10):889-91. PubMed ID: 24217548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
    Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
    Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
    Dong A; Zuo C; Lu J; Wang Y
    Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midline cyst of the prostate mimicking malignancy on FDG PET/CT.
    Kim DW; Jung SA; Park SA; Kim CG
    Clin Nucl Med; 2010 Oct; 35(10):811-2. PubMed ID: 20838295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.
    Minamimoto R; Uemura H; Sano F; Terao H; Nagashima Y; Yamanaka S; Shizukuishi K; Tateishi U; Kubota Y; Inoue T
    Ann Nucl Med; 2011 Jan; 25(1):21-7. PubMed ID: 20931305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
    Siegel C
    J Urol; 2014 Apr; 191(4):986. PubMed ID: 24703123
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There Use for FDG-PET in Prostate Cancer?
    Jadvar H
    Semin Nucl Med; 2016 Nov; 46(6):502-506. PubMed ID: 27825430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT Imaging of Prostate Stromal Tumor of Uncertain Malignant Potential.
    Fabio M; Alfredo B; Antonella C; Stefano P; Sergio B
    Clin Nucl Med; 2021 Apr; 46(4):348-349. PubMed ID: 33492862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate.
    Pan B; Han JK; Wang SC; Xu A
    World J Gastroenterol; 2013 Oct; 19(39):6699-702. PubMed ID: 24151402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
    Schöder H; Herrmann K; Gönen M; Hricak H; Eberhard S; Scardino P; Scher HI; Larson SM
    Clin Cancer Res; 2005 Jul; 11(13):4761-9. PubMed ID: 16000572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late relapse of testicular seminoma in the posterior mediastinum.
    Shin DJ; Kim JS; Kim DY; Yeo JS
    Clin Imaging; 2013; 37(2):406-8. PubMed ID: 23466004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate.
    Dong A; Zhu Y; Zuo C
    Clin Nucl Med; 2022 Aug; 47(8):736-738. PubMed ID: 35797631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT Imaging in an Adolescent Patient With Primary Prostatic Stromal Sarcoma.
    Lai R; Ding C
    Clin Nucl Med; 2019 Jan; 44(1):45-47. PubMed ID: 30394929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we rely on PET in the follow-up of advanced seminoma patients?
    Siekiera J; Małkowski B; Jóźwicki W; Jasiński M; Wronczewski A; Pietrzak T; Chmielowska E; Petrus A; Kamecki K; Mikołajczak W; Kraśnicki K; Chłosta P; Drewa T
    Urol Int; 2012; 88(4):405-9. PubMed ID: 22507953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
    Han EJ; O JH; Park G; Lee J
    Clin Nucl Med; 2017 Aug; 42(8):e381-e382. PubMed ID: 28604478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.